BR112023012460A2 - Conjunto in vitro de capsídeos de anellovirus que envolvem rna - Google Patents
Conjunto in vitro de capsídeos de anellovirus que envolvem rnaInfo
- Publication number
- BR112023012460A2 BR112023012460A2 BR112023012460A BR112023012460A BR112023012460A2 BR 112023012460 A2 BR112023012460 A2 BR 112023012460A2 BR 112023012460 A BR112023012460 A BR 112023012460A BR 112023012460 A BR112023012460 A BR 112023012460A BR 112023012460 A2 BR112023012460 A2 BR 112023012460A2
- Authority
- BR
- Brazil
- Prior art keywords
- anellovirus
- capsids
- rna
- envolve
- vitro set
- Prior art date
Links
- 241001339993 Anelloviridae Species 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title abstract 2
- 210000000234 capsid Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00041—Use of virus, viral particle or viral elements as a vector
- C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063130360P | 2020-12-23 | 2020-12-23 | |
| US202163147064P | 2021-02-08 | 2021-02-08 | |
| PCT/US2021/064887 WO2022140560A1 (en) | 2020-12-23 | 2021-12-22 | In vitro assembly of anellovirus capsids enclosing rna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023012460A2 true BR112023012460A2 (pt) | 2023-11-07 |
Family
ID=82160089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023012460A BR112023012460A2 (pt) | 2020-12-23 | 2021-12-22 | Conjunto in vitro de capsídeos de anellovirus que envolvem rna |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220372519A1 (https=) |
| EP (1) | EP4267157A4 (https=) |
| JP (1) | JP2024501287A (https=) |
| KR (1) | KR20230124682A (https=) |
| AU (1) | AU2021409952A1 (https=) |
| BR (1) | BR112023012460A2 (https=) |
| CA (1) | CA3206361A1 (https=) |
| IL (1) | IL303892A (https=) |
| MX (1) | MX2023007643A (https=) |
| TW (1) | TW202235622A (https=) |
| WO (1) | WO2022140560A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240114778A (ko) * | 2021-12-15 | 2024-07-24 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 표면이 변형된 바이러스 입자 및 모듈형 바이러스 입자 |
| WO2025007075A1 (en) * | 2023-06-29 | 2025-01-02 | Life Technologies Corporation | Molecules resistant to nuclease digestion |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0931158A1 (en) | 1996-09-06 | 1999-07-28 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| CA2559955C (en) | 2004-03-15 | 2016-02-16 | City Of Hope | Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| KR101728655B1 (ko) | 2008-12-18 | 2017-04-19 | 다이서나 파마수이티컬, 인크. | 유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법 |
| US20100249214A1 (en) | 2009-02-11 | 2010-09-30 | Dicerna Pharmaceuticals | Multiplex dicer substrate rna interference molecules having joining sequences |
| US9228242B2 (en) * | 2009-08-21 | 2016-01-05 | Virginia Tech Intellectual Properties, Inc. | Porcine torque teno virus vaccines and diagnosis |
| EP2653562A1 (en) * | 2012-04-20 | 2013-10-23 | Institut Pasteur | Anellovirus genome quantification as a biomarker of immune suppression |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| AU2013335451C1 (en) | 2012-10-23 | 2024-07-04 | Toolgen Incorporated | Composition for cleaving a target DNA comprising a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein, and use thereof |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| EP2840140B2 (en) | 2012-12-12 | 2023-02-22 | The Broad Institute, Inc. | Crispr-Cas based method for mutation of prokaryotic cells |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| IL239344B2 (en) | 2012-12-12 | 2024-06-01 | Broad Inst Inc | Systems engineering, methods and optimal guiding components for sequence manipulation |
| CN113355357B (zh) | 2012-12-12 | 2024-12-03 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| WO2014093655A2 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| IL271275B1 (en) * | 2017-06-13 | 2026-04-01 | Flagship Pioneering Innovations V Inc | Preparations containing croons and their uses |
| CN111819185A (zh) | 2017-12-15 | 2020-10-23 | 旗舰创业创新第六有限责任公司 | 包含环状多核糖核苷酸的组合物及其用途 |
| MX2021006977A (es) * | 2018-12-12 | 2021-10-13 | Flagship Pioneering Innovations V Inc | Anellosomas y metodos de uso. |
| CA3119814A1 (en) * | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering protein replacement therapeutic modalities |
| US11166996B2 (en) * | 2018-12-12 | 2021-11-09 | Flagship Pioneering Innovations V, Inc. | Anellovirus compositions and methods of use |
| KR20230036109A (ko) * | 2020-06-12 | 2023-03-14 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 바큘로바이러스 발현 시스템 |
| MX2022016475A (es) * | 2020-06-17 | 2023-04-11 | Flagship Pioneering Innovations V Inc | Metodos de identificacion y caracterizacion de anellovirus y usos de los mismos. |
-
2021
- 2021-12-22 TW TW110148173A patent/TW202235622A/zh unknown
- 2021-12-22 IL IL303892A patent/IL303892A/en unknown
- 2021-12-22 CA CA3206361A patent/CA3206361A1/en active Pending
- 2021-12-22 EP EP21912150.6A patent/EP4267157A4/en active Pending
- 2021-12-22 JP JP2023538735A patent/JP2024501287A/ja active Pending
- 2021-12-22 KR KR1020237025029A patent/KR20230124682A/ko active Pending
- 2021-12-22 BR BR112023012460A patent/BR112023012460A2/pt unknown
- 2021-12-22 WO PCT/US2021/064887 patent/WO2022140560A1/en not_active Ceased
- 2021-12-22 MX MX2023007643A patent/MX2023007643A/es unknown
- 2021-12-22 AU AU2021409952A patent/AU2021409952A1/en active Pending
-
2022
- 2022-06-22 US US17/846,503 patent/US20220372519A1/en not_active Abandoned
-
2025
- 2025-02-18 US US19/056,060 patent/US20250257368A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021409952A1 (en) | 2023-07-06 |
| KR20230124682A (ko) | 2023-08-25 |
| US20220372519A1 (en) | 2022-11-24 |
| IL303892A (en) | 2023-08-01 |
| EP4267157A4 (en) | 2025-05-07 |
| CA3206361A1 (en) | 2022-06-30 |
| TW202235622A (zh) | 2022-09-16 |
| MX2023007643A (es) | 2023-09-04 |
| WO2022140560A1 (en) | 2022-06-30 |
| EP4267157A1 (en) | 2023-11-01 |
| US20250257368A1 (en) | 2025-08-14 |
| JP2024501287A (ja) | 2024-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2023006684A2 (es) | Anticuerpos contra sars-cov-2 y usos de los mismos | |
| BR112018003486A2 (pt) | ?molécula, rna, métodos para obter rna, métodos para obter um peptídeo e usos do rna? | |
| MX2019002904A (es) | Composiciones de arn de alta pureza y métodos para su preparación. | |
| CL2018000829A1 (es) | Anticuerpos anti-cd19 humano con alta afinidad | |
| UY38003A (es) | Construcciones de arni para inhibir la expresión de pnpla3 y métodos de uso de las mismas | |
| BR112022020780A2 (pt) | Composições de trem e usos das mesmas | |
| MX392571B (es) | Procesos para producir productos de fermentación. | |
| BR112021024956A2 (pt) | Anticorpos multiespecíficos de cadeia pesada que se ligam a cd22 e cd3 | |
| BR112023012460A2 (pt) | Conjunto in vitro de capsídeos de anellovirus que envolvem rna | |
| MX2022001449A (es) | Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos. | |
| BR112013023620A2 (pt) | cano de liga austenítica e método para produzir o mesmo | |
| MX2019005136A (es) | Vacuna contra el parvovirus porcino y el virus del sindrome respiratorio reproductivo porcino y metodos de produccion de esta. | |
| BR112022005026A2 (pt) | Conjugados terapêuticos | |
| MX2020001885A (es) | Formulaciones de daptomicina. | |
| MX2025004075A (es) | Vacunas para circovirus porcino tipo 3 (pcv3), y produccion y sus usos | |
| CL2021000849A1 (es) | Anticuerpos que se unen a la proteína de envoltura del virus zika y usos de los mismos (divisional de la solicitud no. 201900999) | |
| MX2023009882A (es) | Anticuerpos anti-muc1-c y estructuras car-t. | |
| WO2019212356A8 (en) | Tetrazines for high click conjugation yield in vivo and high click release yield | |
| MX2024006407A (es) | Composiciones de inmunogenos del virus varicela-zoster y sus usos. | |
| BR112023021237A2 (pt) | Minicélulas pesticidas e suas composições para aplicações agrícolas | |
| CL2021002838A1 (es) | Anticuerpo anti-bcma conjugado, composiciones que comprenden el mismo, y métodos de fabricación y uso del mismo. | |
| PY2371941A (es) | Métodos y composiciones para mejorar características de rendimiento en plantas | |
| MX2022005358A (es) | Composiciones de copolímero de bloque sensibles al ph, micelas, y métodos de uso. | |
| CL2024000248A1 (es) | Composiciones y métodos para anticuerpos anti-pacap | |
| BR112018000589A2 (pt) | composição de tratamento de cabelo, método para o tratamento de cabelo e utilização de uma composição |